TY - JOUR
T1 - A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κE3′enhancer
AU - Hodawadekar, Suchita
AU - Park, Kyoungsook
AU - Farrar, Michael A.
AU - Atchison, Michael L.
PY - 2012/3/1
Y1 - 2012/3/1
N2 - Stage-specific rearrangement of Ig H and L chain genes poses an enigma because both processes use the same recombinatorial machinery, but the H chain locus is accessible at the pro-B cell stage, whereas the L chain loci become accessible at the pre-B cell stage. Transcription factor STAT5 is a positive-acting factor for rearrangement of distal V H genes, but attenuation of IL-7 signaling and loss of activated STAT5 at the pre-B cell stage corresponds with Igk locus accessibility and rearrangement, suggesting that STAT5 plays an inhibitory role at this locus. Indeed, loss of IL-7 signaling correlates with increased activity at the Igk intron enhancer. However, the κE3′ enhancer must also be regulated as this enhancer plays a role in Igk rearrangement. We show in this study that STAT5 can repress κE3′ enhancer activity. We find that STAT5 binds to a site that overlaps the κE3′ PU.1 binding site. We observed reciprocal binding by STAT5 and PU.1 to the κE3′ enhancer in primary bone marrow cells, STAT5 and PU.1 retrovirally transduced pro-B cell lines, or embryonic stem cells induced to differentiate into B lineage cells. Binding by STAT5 corresponded with low occupancy of other enhancer binding proteins, whereas PU.1 binding corresponded with recruitment of IRF4 and E2A to the κE3′ enhancer. We also find that IRF4 expression can override the repressive activity of STAT5. We propose a novel PU.1/STAT5 displacement model during B cell development, and this, coupled with increased IRF4 and E2A activity, regulates κE3′ enhancer function.
AB - Stage-specific rearrangement of Ig H and L chain genes poses an enigma because both processes use the same recombinatorial machinery, but the H chain locus is accessible at the pro-B cell stage, whereas the L chain loci become accessible at the pre-B cell stage. Transcription factor STAT5 is a positive-acting factor for rearrangement of distal V H genes, but attenuation of IL-7 signaling and loss of activated STAT5 at the pre-B cell stage corresponds with Igk locus accessibility and rearrangement, suggesting that STAT5 plays an inhibitory role at this locus. Indeed, loss of IL-7 signaling correlates with increased activity at the Igk intron enhancer. However, the κE3′ enhancer must also be regulated as this enhancer plays a role in Igk rearrangement. We show in this study that STAT5 can repress κE3′ enhancer activity. We find that STAT5 binds to a site that overlaps the κE3′ PU.1 binding site. We observed reciprocal binding by STAT5 and PU.1 to the κE3′ enhancer in primary bone marrow cells, STAT5 and PU.1 retrovirally transduced pro-B cell lines, or embryonic stem cells induced to differentiate into B lineage cells. Binding by STAT5 corresponded with low occupancy of other enhancer binding proteins, whereas PU.1 binding corresponded with recruitment of IRF4 and E2A to the κE3′ enhancer. We also find that IRF4 expression can override the repressive activity of STAT5. We propose a novel PU.1/STAT5 displacement model during B cell development, and this, coupled with increased IRF4 and E2A activity, regulates κE3′ enhancer function.
UR - http://www.scopus.com/inward/record.url?scp=84857497021&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857497021&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1102239
DO - 10.4049/jimmunol.1102239
M3 - Article
C2 - 22279106
AN - SCOPUS:84857497021
SN - 0022-1767
VL - 188
SP - 2276
EP - 2284
JO - Journal of Immunology
JF - Journal of Immunology
IS - 5
ER -